Ribosomally encoded natural products were once thought to be of limited structural diversity and uncommon amongst microbes. Over the past few years, however, this viewpoint has changed due to the increased discovery rate of RNPs possessing newly described structural motifs previously ascribed to their nonribosomal counterparts. Nearly every sequenced genome, including invertebrates, contains the genetic capacity to biosynthesize ribosomally- encoded, post-translationally modified natural products such as lantibiotics, bacteriocins, microcins, cyanobactins, thiopeptides, and lasso peptides, thereby making this class of underappreciated natural products perhaps the most dominant in all of nature. What is lacking, however, is a systematic approach to harvest this ubiquitous class of natural products and assess their unique biosynthetic capacity. The difficulty associated with characterizing RNPs in a systematic fashion can be attributed to their falling outside the scope of not only most therapeutic screening programs but also metabolomic or proteomic approaches due to their larger size, structural diversity and extraordinary number of post-translational modifications. This proposal outlines the developmental strategies to create a set of tools for harnessing the biosynthetic potential of ribosomally encoded natural products through mass spectrometry based genome mining. The techniques and methodologies created as a result of the proposed work will not only be important for the detection of therapeutic lead compounds, but also for the efficient characterization of ribosomally encoded toxins secreted by pathogenic bacteria such as Staphylococcus aureus, Bacillus cereus and Clostridium difficile as well as defensins produced by higher eukaryotes such as marine snails, primates and humans.
This work outlines an approach that experimentally mines genome sequences for genetically encoded molecules that control biology. Such molecules serve as great lead compounds for therapeutic development.
|Hsu, Cheng-Chih; Dorrestein, Pieter C (2015) Visualizing life with ambient mass spectrometry. Curr Opin Biotechnol 31:24-34|
|Schorn, Michelle; Zettler, Judith; Noel, Joseph P et al. (2014) Genetic basis for the biosynthesis of the pharmaceutically important class of epoxyketone proteasome inhibitors. ACS Chem Biol 9:301-9|
|Yamanaka, Kazuya; Reynolds, Kirk A; Kersten, Roland D et al. (2014) Direct cloning and refactoring of a silent lipopeptide biosynthetic gene cluster yields the antibiotic taromycin A. Proc Natl Acad Sci U S A 111:1957-62|
|Gonzalez, David J; Corriden, Ross; Akong-Moore, Kathryn et al. (2014) N-terminal ArgD peptides from the classical Staphylococcus aureus Agr system have cytotoxic and proinflammatory activities. Chem Biol 21:1457-62|
|Liu, Wei-Ting; Lamsa, Anne; Wong, Weng Ruh et al. (2014) MS/MS-based networking and peptidogenomics guided genome mining revealed the stenothricin gene cluster in Streptomyces roseosporus. J Antibiot (Tokyo) 67:99-104|
|Bouslimani, Amina; Sanchez, Laura M; Garg, Neha et al. (2014) Mass spectrometry of natural products: current, emerging and future technologies. Nat Prod Rep 31:718-29|
|Mohimani, Hosein; Kersten, Roland D; Liu, Wei-Ting et al. (2014) Automated genome mining of ribosomal peptide natural products. ACS Chem Biol 9:1545-51|
|Fang, Jinshu; Dorrestein, Pieter C (2014) Emerging mass spectrometry techniques for the direct analysis of microbial colonies. Curr Opin Microbiol 19:120-9|
|Medema, Marnix H; Paalvast, Yared; Nguyen, Don D et al. (2014) Pep2Path: automated mass spectrometry-guided genome mining of peptidic natural products. PLoS Comput Biol 10:e1003822|
|Winnikoff, Jacob R; Glukhov, Evgenia; Watrous, Jeramie et al. (2014) Quantitative molecular networking to profile marine cyanobacterial metabolomes. J Antibiot (Tokyo) 67:105-12|
Showing the most recent 10 out of 14 publications